The general objectives are to determine the epidemiological and clinical characteristics of survivors of SARS-CoV-2 infection with more than 12 months of diagnosis. Also determine the demographics of infection survivors, risk factors for poor prognosis, epidemiological data on infection, initial symptoms, persistent symptoms, and those without persistent symptoms, among other characteristics.
The anonymous, self-administered survey can be completed through the following form: https://docs.google.com/forms/d/e/1FAIpQLSd0k5MHnEfnYlBGpuU2qmlUtRcqq4PeJ0hSRuTRb9koC8dDUQ/viewform.
The project manager is Professor Mag Pablo A. Olavegogeascoechea and co-director is Dr. Med. Esp. Andrés Gallardo Martínez. The research team consists of: Professor Lysis Andrea Federico, Dr Scabellato, Jose Luis, Dr Jose M. Quiroga, Dr Martin L. Castro, Dr. Sebastian E. Soluaga, and Dr. Alejandro Z.
The survey will reveal the following dimensions: the characteristics of the participants (gender, age, comorbidities, habits); Cases related to COVID-19 (method of diagnosis, presentation of symptoms, duration of symptoms, persistent symptoms after 12 months, vaccination prior to infection, history of infection).
It started in 2021, during the second wave, with the need to characterize the clinical picture that could identify or differentiate between COVID and other viral infections, Pablo Olavigogiascochea emphasized. During this specific work, the focus is on the patients. Between 25 and 55 years old, healthy young adults who begin to experience symptoms unexpected in this age group (dizziness, herpes, memory loss, decreased smell), which is why posts about persistent or prolonged COVID are starting. A good characterization of ongoing COVID is essential. It is an open, anonymous survey that takes no more than 10 minutes to complete.
“It is work that has been submitted to the Ethics Committee in Human Research of the Province of Rio Negro. All data collected is protected by the Personal Data Law, and only members of the research team will have access to it.”
As yet, there is no test to diagnose post-COVID conditions, and people can experience a variety of symptoms that may stem from other health problems. This can make it difficult for health teams to identify post-COVID-related cases. Therefore, the purpose of the study is to identify the epidemiological and clinical characteristics of patients diagnosed with COVID-19 12 months ago or more, which will make it possible to determine the characteristics and number per patient and persistence, in addition to being able to identify indicators in patients with mild disease. and average.
On the basis and theoretical framework of the project
As of December 2019, a series of unexplained cases of severe pneumonia were reported in Wuhan, China. This finding was quickly attributed to infection with the new coronavirus, called Coronavirus 2 (2019-nCoV). On February 11, the World Health Organization (WHO) officially named the disease Coronavirus Disease 2019 (COVID-19). Finally, in March 2020, COVID-19 was declared a pandemic by the World Health Organization.
Currently, the disease has produced 79,052,55 cases and 826.35 deaths per million.
Of the worldwide population, in Argentina these numbers were 213,553.19 cases and 2,856.30 deaths. In Rio Negro Province, for example, as of September 25 this year, the total number of confirmed cases is 152,155 patients and in CABA 1,166,268 the most people in the world have recovered from the disease, however, they report continuing . symptoms after varying periods of time; Depending on the population and types of studies, patients who develop prolonged COVID range from 76% in those with symptoms persisting after 6 months and between 19% and 40% after 1 year.
The consequences are still not well known. For some patients the condition is in multiple organs or systems, for others it is more localized; Many of them can affect the quality of life of individuals, especially those with debilitating and neurocognitive disorders.
It’s also not clear if severe infection carries an increased risk of persistence of symptoms beyond 12 months. Additionally, little research has focused on the persistence of COVID-19 by age group.
Persistent symptoms vary according to the series published, but in general, most agree that weakness, shortness of breath, and memory loss are the most common symptoms.
Those who wish to know more information about it can go to the link: https://medicina.uncoma.edu.ar/index.php/institucional/noticias/investigacion-covid-encuesta/.
